Social engagement
Social engagement: 737 social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
19 investors on record; lead investors include Panacea Venture, Shunwei Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 11 | 58% |
| Private equity | 2 | 11% |
| Other / undisclosed | 6 | 32% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
Based on job postings tracked across public sources.
Recent activity
22 Jun 2026
Event
Building Global Biopharmas panel
10 Jun 2026
Event
2026 FOCIS conference
15 May 2026
Event
Driving Clinical Success in Antibody-Drug Conjugates program at PEGS Boston: The Essential Protein & Antibody Engineering Summit